Description
A very potent inhibitor of sEH (IC50 = 0.5 nM); displays high oral bioavailability for doses ranging from 0.01 to 1 mg/kg; with the COX-2 inhibitor celecoxib, suppresses tumor angiogenesis, inhibiting tumor growth and metastasis in a Lewis lung carcinoma model in mice
Formal name: 4-[[trans-4-[[(tricyclo[3.3.1.13,7]dec-1-ylamino)carbonyl]amino]cyclohexyl]oxy]-benzoic acid
Synonyms:
Molecular weight: 412.5
CAS: 885012-33-9
Purity: ≥90%
Formulation: A crystalline solid
Product Type|Biochemicals|Small Molecule Inhibitors||Research Area|Cancer|Angiogenesis||Research Area|Cancer|Cell Migration & Metastasis